Plato's Pharmacy
Source: https://archive.org/details/derrida-dissemination ↗
Full text: Internet Archive ↗
Derrida's long essay is a forensic reading of a single word.
Plato calls writing a pharmakon, and the word means, at once, remedy and poison — an ambivalence Plato's own translators keep quietly resolving, choosing "cure" or "drug" to fit the argument and thereby erasing the undecidability that was the whole problem.
Derrida's larger claim is that we do this constantly with our tools: we convert a genuine double effect into a slogan so we can stop thinking.
That move is everywhere in the discourse around AI — "a cure for slow research," "the end of real craft" — and it is exactly what a serious practitioner should refuse.
Read alongside the Phaedrus, the essay arms you to hold the ambivalence open, which is the only honest ground from which to decide how to deploy a technology that both extends and atrophies the capacities it touches.
The essay appears in Dissemination, freely readable online.
Central argument
Derrida reads the closing myth of Plato's Phaedrus with obsessive attention to the word pharmakon, which Plato applies to writing and which carries, irreducibly, the senses of both remedy and poison. He argues that the Western tradition — starting with Plato's own translators — repeatedly suppresses this ambivalence, forcing the word into a single meaning and thereby domesticating a genuine undecidability about whether writing supplements or corrupts living thought. Writing is figured as an outside, a supplement, a mere image of speech; Derrida shows that this 'outside' is already at work inside speech and memory themselves, unsettling the hierarchy Plato tried to secure.
Critique
Derrida's method is deliberately vertiginous and can read as a refusal to conclude anything, which frustrates readers looking for a usable verdict on writing or technology. The essay's insights are also purchased at the price of considerable interpretive violence to Plato, and its influence has licensed a great deal of weaker imitation. But the central claim — that we systematically resolve the ambivalence of our tools in order to stop thinking about them — survives independently of the deconstructive apparatus.
Why it matters for product
Every debate about whether a technology 'helps' or 'harms' thinking reenacts the translator's move Derrida exposes: collapsing a genuine ambivalence into a slogan. For product leaders, the discipline the essay teaches is to keep the pharmakon open — to hold, simultaneously, that a tool extends a capacity and erodes another, and to design deployment around that double effect rather than around a marketing verdict. It is the philosophical antidote to both AI boosterism and AI doom.